嘉兴市艾科诺生物科技有限公司

Jiaxing Accunome Biotechnology Company Limited was established in 2018 as a high-tech enterprise specializing in in-vitro diagnostics. Founded by overseas returnee doctors, all members of the leadership team have held positions in multinational IVD companies. With a focus on molecular diagnostics, Accunome is developing an automated diagnostic instrument platform and a range of reagent kits for infectious diseases, cancer, and other critical illnesses to cater to domestic and international markets. The company upholds the principle of "quality first, integrity first," aligning with national industrial policies and global medical market trends, aiming to become a benchmark in the IVD industry.